அஞ்சும் ஜலால் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from அஞ்சும் ஜலால். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In அஞ்சும் ஜலால் Today - Breaking & Trending Today

Vital medicine for heart patients short in market - Newspaper


LAHORE: A vital medicine used for heart-related chest pain (angina) is short in the market across Punjab.
Manufactured by a multinational pharmaceutical company, the life-saving medicine, Angised (0.5mg), was the only available remedy in an emergency. A patient feeling chest pain/heart pain (angina) is suggested to keep it under the tongue to prevent risk to life.
Senior cardiologists and surgeons said the shortage was all over the country and its main reason might be the low price. They held the retailers and distributors responsible for the shortage.
However, there was another opinion that the globally recognised pharmaceutical company had either halted its production or limited it because of some other reasons. ....

Anjum Jalal , Zubair Akram , Rawalpindi Institute Of Cardiology , Punjab Institute Of Cardiology , Drug Regulatory Authority Pakistan , Drug Regulatory , Authority Pakistan , Rawalpindi Institute , Cardiology Chief Executive Prof Dr Anjum , அஞ்சும் ஜலால் , ர்யாவால்பீஂடீ நிறுவனம் ஆஃப் இருதயவியல் , பஞ்சாப் நிறுவனம் ஆஃப் இருதயவியல் , மருந்து ஒழுங்குமுறை அதிகாரம் பாக்கிஸ்தான் , மருந்து ஒழுங்குமுறை , அதிகாரம் பாக்கிஸ்தான் , ர்யாவால்பீஂடீ நிறுவனம் , இருதயவியல் தலைமை நிர்வாகி ப்ரொஃப் டாக்டர் அஞ்சும் ,

Vital medicine for heart patients short in Punjab markets - Pakistan


LAHORE: A vital medicine used for heart-related chest pain (angina) is short in the market across Punjab.
Manufactured by a multinational pharmaceutical company, the life-saving medicine, Angised (0.5mg), was the only available remedy in an emergency. A patient feeling chest pain/heart pain (angina) is suggested to keep it under the tongue to prevent risk to life.
Senior cardiologists and surgeons said the shortage was all over the country and its main reason might be the low price. They held the retailers and distributors responsible for the shortage.
However, there was another opinion that the globally recognised pharmaceutical company had either halted its production or limited it because of some other reasons. ....

Anjum Jalal , Zubair Akram , Rawalpindi Institute Of Cardiology , Punjab Institute Of Cardiology , Drug Regulatory Authority Pakistan , Drug Regulatory , Authority Pakistan , Rawalpindi Institute , Cardiology Chief Executive Prof Dr Anjum , அஞ்சும் ஜலால் , ர்யாவால்பீஂடீ நிறுவனம் ஆஃப் இருதயவியல் , பஞ்சாப் நிறுவனம் ஆஃப் இருதயவியல் , மருந்து ஒழுங்குமுறை அதிகாரம் பாக்கிஸ்தான் , மருந்து ஒழுங்குமுறை , அதிகாரம் பாக்கிஸ்தான் , ர்யாவால்பீஂடீ நிறுவனம் , இருதயவியல் தலைமை நிர்வாகி ப்ரொஃப் டாக்டர் அஞ்சும் ,